NEW YORK (TheStreet) -- CHANGE IN RATINGS:ACCO Brands ( ACCO) upgraded to buy at TheStreet Ratings. Apple ( AAPL) downgraded at Jefferies to hold from buy, Jefferies said. $500 price target. Demand slowdown and margin pressure. Albermarle ( ALB) downgraded at JP Morgan from overweight to neutral, JP Morgan said. Valuation call, based on a $67 price target. Albermarle downgraded at Deutsche from buy to hold, Deutsche Bank said. $70 price target. Company lacks near-term catalysts. Albemarle downgraded at Citigroup to neutral from buy, Citigroup said. $71 price target. Weaker bromine trends. Altera ( ALTR) downgraded at William Blair from outperform to market perform, William Blair said. Margins may have peaked as the company is facing product cycle headwinds. Astoria Financial ( AF) upgraded to buy at TheStreet Ratings. Bed Bath & Beyond ( BBBY) upgraded at Oppenheimer to outperform from perform, Oppenheimer said. $71 price target. One of best-run companies in retail. Cubist Pharmaceuticals ( CBST) upgraded at Cantor from sell to hold, Cantor Fitzgerald said. Valuation call, based on a $38 price target. Dillard's ( DDS) upgraded at Credit Suisse from neutral to outperform, Credit Suisse said. $95 price target. Company is prepared for a shift in retail spending. Emerson Electric ( EMR) upgraded at Deutsche from hold to buy, Deutsche Bank said. $68 price target. China and other emerging markets can continue to drive growth over the next several quarters. Energizer ( ENR) downgraded at BMO from outperform to market perform, BMO Capital said. $95 price target. Valuation call, as the stock is up 30% since August. Flowserve ( FLS) downgraded at Wedbush from outperform to neutral, Wedbush said. $160 price target. Valuation call, as the stock is up 45% over the past year. Molycorp ( MCP) downgraded at Dahlman from buy to hold, Dahlman Rose said. Company continues to increase its capital spending. $8.13 price target. Netflix ( NFLX) upgraded at JP Morgan from neutral to overweight, JP Morgan said. $180 price target. Company is carrying a lot of momentum into 2013. Netflix upgraded at Lazard to buy, Lazard Capital Markets said. $200 price target. Once again appears that the company can deliver strong growth domestically. Netflix downgraded at Credit Suisse from outperform to neutral, Credit Suisse said. $132 price target. A lot of variability remains in the business model.
STOCK COMMENTS / EPS CHANGESApple ( AAPL) numbers lowered at Oppenheimer. Shares of AAPL now seen reaching $600, Oppenheimer said. Estimates also lowered on disappointing guidance. Outperform rating. Apple estimates, target reduced at BMO.AAPL estimates were cut through 2014, BMO Capital said. Company lowered its guidance. Outperform rating and new $580 price target. Apple numbers cut at UBS. Shares of AAPL now seen reaching $600, UBS said. Estimates also lowered on mediocre outlook. Buy rating. Apple estimates, target cut at Sterne Agee. Shares of AAPL now seen reaching $715, according to Sterne Agee. Estimates also reduced, given the company's new guidance. Buy rating. Apple numbers cut at Citigroup. Shares of AAPL now seen reaching $500, Citigroup said. Estimates also lowered on weaker iPhone shipments. Neutral rating. Abbvie ( ABBV) estimates, target boosted at BMO. Shares of ABBV now seen reaching $41, according to BMO Capital. Estimates also upped, given highrer Humira growth. Outperform rating. Amgen ( AMGN) target raised at Bernstein to $101, Bernstein said. Solid quarter, but lacking near term catalysts. Market Perform rating. Baker Hughes ( BHI) numbers cut at BMO. Shares of BHI now seen reaching $43, BMO Capital Markets said. Estimates also lowered on outlook which lacks sense of urgency. Market Perform rating. Baker Hughes target raised at Jefferies to $48, Jefferies said. DCF mechanics. Hold rating.
Twitter and become a fan on Facebook.